These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 24258613)
1. Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis. Yin M; Zhou J; Gorak EJ; Quddus F Oncologist; 2013; 18(12):1248-55. PubMed ID: 24258613 [TBL] [Abstract][Full Text] [Related]
2. Metformin may improve the prognosis of patients with pancreatic cancer. Zhang JW; Sun Q Asian Pac J Cancer Prev; 2015; 16(9):3937-40. PubMed ID: 25987064 [TBL] [Abstract][Full Text] [Related]
3. Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis. Shi YQ; Zhou XC; Du P; Yin MY; Xu L; Chen WJ; Xu CF Medicine (Baltimore); 2020 Sep; 99(37):e21687. PubMed ID: 32925714 [TBL] [Abstract][Full Text] [Related]
4. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis. Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955 [TBL] [Abstract][Full Text] [Related]
5. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis. Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293 [TBL] [Abstract][Full Text] [Related]
6. Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: A meta-analysis. Zeng S; Gan HX; Xu JX; Liu JY Med Clin (Barc); 2019 Apr; 152(8):291-297. PubMed ID: 30173870 [TBL] [Abstract][Full Text] [Related]
7. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis. Meng F; Song L; Wang W J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076 [No Abstract] [Full Text] [Related]
8. Metformin therapy associated with survival benefit in lung cancer patients with diabetes. Wan G; Yu X; Chen P; Wang X; Pan D; Wang X; Li L; Cai X; Cao F Oncotarget; 2016 Jun; 7(23):35437-45. PubMed ID: 27105507 [TBL] [Abstract][Full Text] [Related]
9. Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis. Xin WX; Fang L; Fang QL; Zheng XW; Ding HY; Huang P Medicine (Baltimore); 2018 Mar; 97(9):e0035. PubMed ID: 29489653 [TBL] [Abstract][Full Text] [Related]
10. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis. Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122 [TBL] [Abstract][Full Text] [Related]
11. Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality. Xu H; Aldrich MC; Chen Q; Liu H; Peterson NB; Dai Q; Levy M; Shah A; Han X; Ruan X; Jiang M; Li Y; Julien JS; Warner J; Friedman C; Roden DM; Denny JC J Am Med Inform Assoc; 2015 Jan; 22(1):179-91. PubMed ID: 25053577 [TBL] [Abstract][Full Text] [Related]
12. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus. Perez-Lopez FR; Pasupuleti V; Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Hernandez AV Maturitas; 2017 Jul; 101():6-11. PubMed ID: 28539171 [TBL] [Abstract][Full Text] [Related]
13. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis. Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254 [TBL] [Abstract][Full Text] [Related]
14. The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis. Li Y; Hu L; Xia Q; Yuan Y; Mi Y Int Urol Nephrol; 2017 Jun; 49(6):975-981. PubMed ID: 28271326 [TBL] [Abstract][Full Text] [Related]
15. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis. Cheng Y; Chen Y; Zhou C; Shen L; Tu F; Xu J; Liu C Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):73-81. PubMed ID: 31300371 [TBL] [Abstract][Full Text] [Related]
16. Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy. Richards KA; Liou JI; Cryns VL; Downs TM; Abel EJ; Jarrard DF J Urol; 2018 Dec; 200(6):1256-1263. PubMed ID: 29940252 [TBL] [Abstract][Full Text] [Related]
17. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis. Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848 [TBL] [Abstract][Full Text] [Related]
18. The effect of metformin on mortality following cancer among patients with diabetes. Lega IC; Shah PS; Margel D; Beyene J; Rochon PA; Lipscombe LL Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1974-84. PubMed ID: 25030683 [TBL] [Abstract][Full Text] [Related]
19. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies. Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials. Gebrie D; Getnet D; Manyazewal T Sci Rep; 2021 Jan; 11(1):137. PubMed ID: 33420333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]